Gary Brecka explains how cytochrome P450 enzymes and immune pathways process toxins and pathogens. When these systems fail, it cascades to problems in your microbiome, heart, and brain. Genetic variations determine how well your body handles chemotherapy, vaccines, and other treatments.
What kind of biomarkers are you finding that are indicative of some of these pathogens? Like, what are you going to see in somebody with metals or with Lyme.
When we would develop human monoclonal antibodies or different pharmaceuticals? We're looking at P450 systems within the body and the IL2 and IL4 pathways. And you even look at those pathways when you give a patient a chemotherapy, a radiation, or human monoclonal antibody or a vaccine. And we know now that if those systems are not working within the body, then your whole system isn't working. Your microbiome within the stomach is not producing hydrogen, you're not communicating with the heart, you're not communicating with the brain. And even though it sounds really simple, those are your main pathways that you're really looking at genetically to work at processing anything you put in the body.
